Opinion – Tuesday 15 December 2020

After trading to new all-time highs earlier in the session, U.S. Equity markets sold off throughout the day on fears of another shutdown led by the Dow which closed 0.62% lower. The U.S had joined the UK by rolling out the COVID-19 vaccine. Late Friday, the U.S. Food...

Opinion – Monday 14 December 2020

Stimulus uncertainty weighed on U.S. Equity Markets, finishing the day lower, led by the Russel 2000, which closed with a loss of 0.57%. worries over halted coronavirus vaccine trials and stimulus breakdowns weighed on markets. Sanofi and GlaxoSmithKline halted their...

Opinion – Friday 11 December 2020

U.S. Equity Markets recovered some of its earlier losses to end the day mixed. The S&P ended the session, closing -0.13% lower while the Russell 2000 again outperformed closing higher by 1.08%. A sharp rise in Jobless claims weighed on markets. Jobless Claims...

Opinion – Thursday 10 December 2020

Fears of a breakdown in Stimulus talks weighed on U.S. Equity Markets, which finished the day lower, led by the NASDAQ 100 which closed with a hefty loss of 2.15%. Late Tuesday, Treasury Secretary Steven Mnuchin proposed a Coronavirus Stimulus Bill to Speaker of the...

Opinion – Wednesday 9 December 2020

Vaccine optimism once again boosted U.S. Equity Markets, closing at new all-time highs, led by the Russel 2000 closing with a gain of 1.40%. After opening lower, vaccine news provided tailwinds for markets over the course of the day. An analysis by U.S. Food and Drug...

Opinion – Tuesday 8 December 2020

U.S. Equity markets declined to start the week, led by the Dow which closed lower by 0.49%. This is the first Monday since the end of October that we have not had a ‘’gap’’ move higher. Coronavirus trends put downward pressure on markets. Stay-at-home orders went into...